O PREVENT BLINDNESS in their patients with diabetes, primary care physicians need to take a more active role in overseeing and managing their ophthalmic care-in particular, making sure that every patient with diabetes receives an eye examination with pupil dilation to screen for retinopathy at least once a year.
See related editorial, page 81
Diabetic retinopathy remains the numberone cause of blindness in the developed world. Treatments can arrest its development but not restore lost vision. Fortunately, screening examinations can detect it in its early clinical stages. Yet only about half of patients with diabetes actually receive this recommended examination.
In this article we outline the case for eye screening and recommend ways that primary care physicians can help.
s HOW SUGAR DAMAGES THE EYE
Diabetic retinopathy begins with hyperglycemia, but how sugar causes the characteristic occlusion and leakage of the small vessels in the retina, with resulting progressive vision loss, is still largely unknown. 1 Capillary occlusion. One intriguing hypothesis is that, in the small arteries of target organs, hyperglycemia activates white s KEY POINTS Instead of simply telling the patient to get an eye examination, the internist should make the referral, write a letter to the ophthalmologist, and expect a report in return.
Strict control of blood sugar levels reduces the incidence of diabetic retinopathy by about 35% for every 1% absolute decrement in hemoglobin A 1c . Still, more than 80% of diabetic patients eventually develop some degree of retinopathy.
Laser treatment and surgery can usually arrest the progression of retinopathy but usually cannot restore lost vision.
Retinal photography holds promise for screening: photographs can be taken by trained personnel (not necessarily a physician) in the internist's office, with or without pupil dilation, and analyzed by computer algorithms or an eye care provider at a later date.
T blood cells, making them stiffer 2 and more resistant to flow. 3, 4 In addition, the white blood cells express more molecules on their surfaces called integrins, notably CD11a, CD11b, and CD18, and capillary endothelial cells express intercellular adhesion molecules (ICAMs); the two types of molecules stick together like Velcro, and the white blood cells adhere to the capillary wall.
Owing to these effects, the white blood cells cannot pass through the capillaries of target organs as easily as they should. Ultimately, the capillaries become plugged, and progressively larger areas of the retina are deprived of perfusion. 5, 6 In the early stages of capillary occlusion, the surrounding capillaries compensate by accepting more flow, but as more capillaries and even arterioles are occluded, this autoregulation fails, and wider areas of the retina become ischemic. 7, 8 Leakage, edema, exudates. When white blood cells adhere to the endothelium, they release products that make it more permeable. 6 Furthermore, in response to ischemia, the vascular endothelium increases its production of various compensatory factors, most notably vascular endothelial growth factor (VEGF), 9,10 a potent enhancer of permeability.
With the endothelium more permeable, more fluid leaks into the retina, resulting in tissue edema. 11 Exudates of edematous fluid and cholesterol accumulate in the retina (FIG-URE 1, FIGURE 2) , causing opacification and swelling and impairing vision resolution and contrast sensitivity.
Neovascularization. VEGF also stimulates new blood vessels to grow in the nonperfused areas, a process called neovascularization. 12 However, for reasons unknown, the new vessels grow in the wrong plane, between the internal surface of the retina and the vitreous gel (FIGURE 3) .
Fibrosis. Along with the new vessels, fibrous tissue proliferates, producing local and then more widespread gel retraction that can tear the new vessels, causing bleeding between the gel and retina. The bleeding causes "floaters," or, if more severe, it causes more diffuse loss of vision. Ultimately, the hemorrhage stimulates more fibrous tissue. As the fibrous tissue contracts, it pulls on the retina, distort- ing and detaching it, both of which can cause severe vision loss.
s TREATMENT HALTS RETINOPATHY, BUT CANNOT RESTORE VISION
Treatments for diabetic retinopathy are either local or systemic.
Local treatments: Laser and surgery Focal laser treatment. If there is edema in the macula or the central fovea, where it threatens central vision, one must first identify the leaking microvascular lesions by injecting sodium fluorescein (a fluorescent dye) intravenously and photographing its transit through the retinal vessels.
Treatment consists primarily of fine laser cauterization, targeting the specific microvessels that are leaking, which may be few and focal if discovered in the early stages.
In a multicenter study, 13 such laser treatment reduced edema and, in 50% of cases, prevented significant loss of central vision. Rarely, however, does it improve vision. Moreover, laser treatment can scar the retina around the fovea and damage periaxial vision. 14 Therefore, laser treatment is most effective when the macular edema is discovered early, when vision impairment is still minimal and the areas of leakage are fewer and more focal.
Scatter laser treatment. If there is neovascularization, the areas of peripheral capillary nonperfusion are identified using the same intravenous fluorescein angiographic procedure and are treated with a scatter method of laser treatment (panretinal photocoagulation).
This procedure indirectly causes involution and fibrosis of the neovascularization, reducing the risk of severe hemorrhage or traction detachment by 60%. 15 The apparent mechanism by which laser treatment reduces edema and neovascularization is thought to be by decreasing production of VEGF and by down-regulating VEGF receptors. 9, 12 Surgery. If neovascularization is discovered late, when there is serious hemorrhage, fibrous tissue growth, or distortion or detachment of the retina, then the patient must undergo a surgical procedure called pars plana vitrectomy.
In this procedure the gel is removed and the fibrous tissue carefully excised from the surface of the retina. 16, 17 During the surgery, additional scatter laser treatment is often given to reduce tissue ischemia, especially if laser treatment has not been given earlier.
More recently, vitrectomy has been performed for cases of edema in which the leakage is more widespread or unresponsive to focal laser treatments. [18] [19] [20] During vitrectomy, steroids may be injected to assist in resolving the macular edema, or an intraocular device may be inserted that slowly releases angiostatic steroids, currently under investigation for the treatment of macular edema. 21, 22 Systemic treatments: Correcting hyperglycemia Systemic factors that exacerbate the course of diabetic retinopathy include hyperglycemia, hypertension, hyperlipidemia, anemia, obstructive sleep apnea, and smoking. We will discuss hyperglycemia here; the other factors will be the topic of a paper to follow.
Tight control of blood sugar has been the standard of care since it was shown to reduce the incidence of retinopathy in insulin-dependent diabetes in the DCCT (Diabetes Control and Complications Trial) 23 and in noninsulin-dependent diabetes in the UKPDS (United Kingdom Prospective Diabetes Study). 24 In both studies, for every decrease in hemoglobin A 1c of 1 absolute percentage point, the incidences of both the onset of retinopathy and of significant progression decreased by approximately 35%.
Nevertheless, even now, more than 80% of people with type 2 diabetes and 97% of those with type 1 diabetes still develop some degree of retinopathy within 15 years, and 40% develop proliferative retinopathy. 25, 26 Numerous drugs have been tested to determine if they prevent the microvascular complications of hyperglycemia. Unfortunately, clinical studies of aldose reductase inhibitors, 27, 28 aminoguanidine, 29 and histamine blockers were unsuccessful. Clinical trials of protein kinase C inhibitors are in progress. 30 Although some new devices (eg, noninvasive monitors and closed-loop insulin delivery systems) and drugs (eg, metformin to manage insulin resistance) may help improve glucose control, it is doubtful that the prevalence of retinopathy or the rate of its progression will be stemmed, given the rising tide of diabetes prevalence. 31 
s THE CASE FOR RETINOPATHY SCREENING
Even though laser and surgical treatment can reduce severe vision loss by up to 94%, diabetic retinopathy remains the leading cause of blindness in the developed world. 32 It is the major cause of new blindness, the leading cause of blindness among working-age people (ages 25 to 74), 26, 33 and a major cause of prolonged disability. Furthermore, these depressing statistics have not improved in the last 10 years.
The problem is that although laser treatment prevents damaged vision from getting worse, it only rarely improves vision. 13 If we wait until the patient complains of blurred vision, it is too late-there is already permanent retinal injury, and the lost vision almost never can be restored.
Therefore, retinopathy demands a new standard of care: regular screening of people without symptoms. 34 In communities in which intensive retinopathy screening programs have been implemented, rates of vision loss have decreased. 35, 36 In view of these successes, the American Diabetes Association, 37 the American Academy of Ophthalmology, 38 the American Academy of Optometry, 39 
Screening should begin in patients with type 2 diabetes shortly after the time of diagnosis and in those with type 1 approximately 3 to 5 years after diagnosis.
s BARRIERS TO RETINOPATHY SCREENING

Patient misunderstanding, noncompliance
At present, only 35% to 55% of people with diabetes actually get an examination of the retina with pupil dilation every year. [40] [41] [42] [43] [44] [45] The rate appears lower among people with type 2 diabetes, 40 but does not vary with socioeconomic or educational level or type of insurance. 41, 46 Why is the rate so low? Perhaps physicians are not talking to their patients about eye care and are not making the referrals. 40,47-49 They may not have time for it, given the many other health problems of patients with diabetes. Overwhelmingly, however, the problem appears to be due to patient misunderstanding and noncompliance.
Although most diabetic patients believe that yearly eye examinations are needed, 40 many do not follow through with scheduling, for several reasons.
• Fear of discovering something bad was commonly reported in a survey of diabetic patients. 50 Although patients may be aware that retinopathy can have severe consequences, as long as they perceive no visual problems, they do not personalize this information.
Factors that worsen retinopathy: Hyperglycemia Hypertension Hyperlipidemia Anemia Sleep apnea Smoking
• Reluctance to make yet another appointment. An eye examination, in which the pupils are dilated, can cost a day lost from work.
• Mixed signals from physicians. Many patients report that their physicians advised them to get annual examinations, but they were also told that they could avoid complications if they controlled their blood sugar better. Then if the physician does not continually admonish his or her patients about their blood sugar control, the patients interpret this as meaning they are "doing all right" and therefore are not at risk of developing retinopathy, and so they may skip the examination.
In one study, the compliance rate increased significantly after patients participated in a blindness-prevention program, but whether this behavior persists is unknown. 51 Poor physician communication A second cause of the low rate of screening is poor communication among physicians.
After the internist advises the patient about the eye examination, he or she then assumes it is the patient's responsibility to follow through and "comply." Often, the internist does not know the name of the eye doctor, and few internists routinely write a letter to the eye doctor with the reasons for the requested examination, the patient's hemoglobin A 1c level, or other information such as comorbidities.
Therefore, even when patients do schedule an eye appointment, very often the optometrist or ophthalmologist does not know the reason for the visit, may take only a cursory history, and may not perform the necessary dilated-pupil examination.
Although some eye care providers send the internist a report, rarely do they communicate when a patient fails to come in for an examination. Furthermore, when internists do receive a report about the examination, they often find that it contains ophthalmic language that they do not understand.
s SHOULD PRIMARY CARE PHYSICIANS PERFORM RETINAL SCREENING?
Whether primary care physicians should screen for retinopathy is controversial. 49 However, the only medical systems in which the retinal examination rates exceed 80% to 85% are those in which screening is provided in the primary care setting (most often by photography; Kaiser Permanente, Joslin Clinic, Louisiana State University, personal communication). 34
Do internists do a good job of screening?
Although internists look at the retinal fundi in up to half of their diabetic patients, 47 they generally do not dilate the pupils, and therefore most often do an inadequate examination. 47, 48 When asked why they did not dilate the pupils, internists mentioned fear of inducing angle-closure glaucoma, the length of time required, and resulting complaints from patients. 52 How real are these concerns? Millstein et al 53 calculated that angle-closure glaucoma was induced in only 1 in 20,000 dilated-pupil examinations, and suggested a simple test to identify people who have a convex iris plane and are at increased risk and should not undergo pupil dilation: shine a flashlight sideways from the lateral side of the eye across the anterior segment. If the iris plane is convex, the nasal side of the iris will be in shadow.
Although time may be a deterrent in a busy internist's schedule, adequate pupil dilation actually takes less than 15 minutes. 53 Patients say that, indeed, pupil dilation does alter their daily schedule more than office visits that do not involve pupil dilation, 52 but for the most part patients still accomplish necessary tasks. If they are forewarned that their pupils will be dilated, they bring sunglasses, and rather than complain, they appreciate the better care and attention. 52 Even with pupil dilation, however, can internists recognize diabetic lesions with sufficient accuracy? Sussman et al 54 found that internists, diabetologists, and medical residents, examining the fundi of diabetic patients with pupils dilated, correctly identified fewer than 60% of the more significant lesions, whereas ophthalmologists and retinal specialists identified more than 96%. This is understandable, considering that the median exposure to ophthalmic disease in medical school was less than 15 hours in 1979, and has continued to decline. 55 Residency
If we wait for blurred vision to develop, it is too late programs in internal medicine or family practice do not usually emphasize ophthalmoscopy, either. In an eloquent editorial, Wender 49 questions the ability of practitioners to maintain adequate skills when they rarely perform this procedure.
Retinal photography shows promise
Retinal photography appears promising as a screening method in the primary care setting. 56 In this method, a trained photographer, nurse, or other health worker takes pictures of the retina, which an ophthalmologist may analyze later or, in some systems (undergoing evaluations), which may be analyzed by computer algorithms.
With pupil dilation, retinal photography, performed in a systematic manner by a trained photographer, has been demonstrated to be superior to direct examination in identifying retinopathy lesions. 57 Even without pupil dilation, early studies suggest that this procedure, performed with a special nonmydriatic camera, may offer a viable and even preferable method for detecting retinopathy in primary care settings. [58] [59] [60] [61] However, the quality of the images and the derived sensitivity and specificity of the detection methods are yet to be determined in studies of large numbers of patients. Until then, retinal photography must be considered investigational and unproven. 62 
s TEAMWORK IS NEEDED
Only by teamwork among health care professionals can blindness from diabetic retinopathy be significantly reduced. We offer the following recommendations.
The primary care physician's job We propose that, in patients with diabetes, it is the responsibility of the primary care physician to:
• Optimize glycemic control (goal hemoglobin A 1c level < 7%) 37 • Aggressively manage other risk factors for retinopathy, eg, hypertension, hyperlipidemia, anemia, obstructive sleep apnea, and smoking • Make sure all patients with diabetes (type 2 as well as type 1) receive an annual retinal examination with pupil dilation or retinal photography, no matter how good their vision seems-and if the hemoglobin A 1c level is more than 12%, we strongly recommend an examination every 6 months. To improve patient compliance, physicians need to:
• Educate their diabetic patients about the importance of getting an annual eye examination • Either make the appointment for the patient or give the patient a note with the eye care provider's name and telephone number • Communicate to the eye care provider the reason for the visit (ie, for a dilated ophthalmic examination), the hemoglobin A 1c level, and the presence of any other comorbid conditions (perhaps by faxing a form such as in FIGURE 4) • If an eye doctor is not available, examine the retina, but only with pupil dilation and with adequate training. However, if there are referred eye physicians available, we recommend that primary physicians do not examine the fundi (without pupil dilation), as this gives the wrong message to the patient.
• Expect a letter from the eye care physician regarding whether the patient was seen, the status of the retinopathy, and recommendations for follow-up. If such a letter is not received within a reasonable time (2-3 months), it is the primary care physician's responsibility to communicate with the patient and with the eye care provider.
• Reinforce any recommendations for follow-up care established by the eye care provider and be knowledgeably abreast of the treatment and results.
Diabetes educators can help
We recognize that these responsibilities place an additional burden on internists, who already have a multitude of recommendations to follow from multiple organizations about preventing different diseases. 49 As medicine becomes more complex, physicians are expected to do more and more. The only way they can do it all is by delegating work to others, whom they supervise. Would you please be so kind as to communicate the results of your examination with specific regard to the absence or presence of retinopathy and your findings, along with the recommendations for follow-up. You may do this either by faxing this convenient form to #_________________, by mailing the form, or by sending a letter. If the patient fails to make the scheduled appointment, please also notify this office.
Thanking you in advance for your assistance on behalf of our patient, economies of scale. Many diabetes educators now talk about ophthalmic care, and may facilitate the eye care provider's appointment and follow-up. It remains the primary care physician's responsibility, however, to make sure that services are provided and a report is generated.
Sincerely yours, ---------------------------------
Results of examination
To remind practitioners and patients what to do, it is helpful to use flow charts and computer-based or paper-based management processes. [63] [64] [65] In addition, the problem of diabetic retinopathy calls for programs to promote physician communication, public awareness and education, and insurance payer education.
The eye care physician's job
If an eye care physician provides the services, it is his or her responsibility to:
• Understand the reasons for the visit and to perform the necessary funduscopy with pupil dilation • Generate a report that is returned to the primary care physician, which provides, in readable format, the results of the examination and the appropriate recommendations for follow-up given the duration of diabetes, the retinopathy grade, the level of hemoglobin A 1c , and the existence of other comorbid conditions • If the patient does not present for a scheduled examination, inform the internist, contact the patient and reinforce the reason for the examination, and make sure that an appointment is rescheduled (perhaps using a form such as in FIGURE 4).
